August 2017

An update on the labeling changes from the FDA.

The phase III ATLANTIS trial is testing the investigational synthetic analogue lurbinectedin in combination with doxoubicin for use in patients with recurrent small cel lung cancer (SCLC).

A navigator's simple idea to bring her therapy dog to the cancer clinic reaped enormous benefits for patients and her colleagues.

Regina Cunningham discusses her path from oncology nurse to hospital system CEO and shares insights on how nurses can leverage their unique skills to assume leadership roles.

Obesity has overtaken smoking as the leading preventable cause of cancer. Among patients diagnosed with cancer, obesity has been linked to poor prognosis.

Confusion about sunscreen options and ingredients can lead to inadequate sun protection and increased skin cancer risk. The Environmental Working Group has resources to help.

Preventing central line–associated bloodstream infections is a top priority for healthcare practitioners, and following basic safety protocols, such as handwashing and line flushing, is essential to the effort.

Nurse navigators at Sarah Cannon use oncology pathways to help ensure patient access to seamless care across the cancer continuum.